Načítá se...

Oncogenic and drug sensitive NTRK1 rearrangements in lung cancer

We identified novel gene fusions in patients with lung cancer harboring the kinase domain of the NTRK1 gene that encodes the TRKA receptor. Both the MPRIP-NTRK1 and CD74-NTRK1 fusions lead to constitutive TRKA kinase activity and are oncogenic. Treatment of cells expressing NTRK1 fusions with inhibi...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Vaishnavi, A., Capelletti, M., Le, A.T., Kako, S., Butaney, M., Ercan, D., Mahale, S., Davies, K.D., Aisner, D.L., Pilling, A.B., Berge, E.M., Kim, J., Sasaki, H., Park, S., Kryukov, G., Garraway, L.A., Hammerman, Peter S., Haas, J., Andrews, S.W., Lipson, D., Stephens, P.J., Miller, V.A., Varella-Garcia, M., Jänne, P.A., Doebele, R.C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3823836/
https://ncbi.nlm.nih.gov/pubmed/24162815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.3352
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!